We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Adopts Final ICH M7(R1) Mutagenic Carcinogen Guideline
FDA Adopts Final ICH M7(R1) Mutagenic Carcinogen Guideline
Potential or actual impurities in drugs should be studied for their mutagenic properties, according to a revision to an ICH guideline addendum on mutagenic carcinogens, now adopted by the FDA.